C O M M U N I C A T I O N S
Figure 4. Human embryonic stem cells plated on arrays formed by spotting
various percentages of PEG acid-AT (indicated) and polyol-AT on bare
gold squares surrounded by a fluoro-AT SAM. (A) Fixed (2% paraform-
aldehyde) and stained (Coomassie) Human ES cells (the 100% spot was
spatially separated but in the same array). (B) Human ES cells on 100%
PEG Acid-AT SAM stained for alkaline phosphatase activity. All squares
are 750 µm in length.
The data indicate that our method for fabricating ligand-
presenting arrays can be used for cell-based screens. We have shown
that arrays generated by this strategy can present combinations of
ligands; different cell lines can “read” the same surfaces differently.
Given the flexibility of our design, we anticipate that it can be used
to present virtually any single AT or combination of synthetic ATs.
We expect that this method can be used to fabricate arrays that
address fundamental questions critical for understanding and
controlling the adhesion, proliferation, and differentiation of cells.
Figure 3. Two cell lines plated on arrays formed by spotting with various
percentages of peptide-ATs and polyol-AT on bare gold squares surrounded
by a fluoro-AT SAM. (A) Fixed (2% paraformaldehyde) and stained
(Coomassie) Swiss 3T3 fibroblast cells. (B) Fixed and stained SH-SY5Y
neuroblastoma cells. “100% -COOH” indicates PEG acid-AT. The label
“-GYIGSR” denotes the peptide-AT derivatized with the sequence
GSDPGYIGSR. All squares are 750 µm in length.
In physiological settings, cells interpret cues from the extra-
cellular matrix. Different cell types interact with different matrix
proteins. The sequence RGD, which is found in a number of
proteins, including fibronectin and vitronectin, binds a family of
integrins on the surface of some cell lines, including Swiss-3T3
fibroblasts. This binding is specific; a simple Arg to Lys substitution
obliterates adhesion.10 Alternatively, the peptide YIGSR, a sequence
found in the matrix protein laminin, interacts with neuroblastoma
cell lines but not with fibroblasts.11 Therefore, surfaces displaying
YIGSR are expected to bind the neuroblastoma cell line and the
fibroblast cell line is expected to adhere preferentially to RGD
surfaces over those presenting KGD.
Acknowledgment. We thank P. J. Belshaw, E. Endler, and R.
Corn for helpful discussions for use of equipment. This research
was supported by DARPA and the W. M. Keck Foundation. B.P.O.
thanks the NIH (AG19550) for a postdoctoral fellowship.
Supporting Information Available: Synthetic methods and ex-
perimental details for the development of the methodology (PDF). This
References
To test whether surfaces displaying different peptides interact
selectively with different cell types, a surface displaying fluoro-
AT SAM was photopatterned. Mixtures of polyol-AT and peptide-
AT12 were spotted on the bare gold. An array element known to
bind cells, 100% PEG acid-AT, and one that resists cell binding,
100% polyol-AT, were also spotted. Swiss 3T3 and SH-SY5Y cells
were plated on the resulting chips, allowed to proliferate, fixed,
and stained. The Swiss 3T3 fibroblasts (Figure 3A) preferentially
bound the RGD surface; minimal binding was detected to the KGD
element. Modest fibroblast adhesion to the YIGSR-modified surface
was observed; as the percentage of polyol-AT was increased,
however, cell binding fell off more rapidly than did binding to RGD-
presenting surfaces. The neuroblastoma cell line, SH-SY5Y (Figure
3B), adheres to the YIGSR-substituted surface but not to either
the RGD or KGD elements. Thus, cell-line specific binding profiles
can be established using these arrays.
Human embryonic stem (ES) cells are developmental precursors
to all cell types and thus termed “pluripotent”.13 The ability to
culture human ES cells on synthetic surfaces would eliminate the
complications of using mouse embryonic fibroblasts as a feeder
layer during ES expansion.14 To determine whether our method
can be used to identify surfaces upon which to culture human ES
cells, solutions of different molar ratios of PEG acid-AT and polyol-
AT were employed to generate arrays upon which human ES cells
were plated. Again, a gradient of cell attachment was observed
(Figure 4). The human ES cells, however, require a more acidic
surface than the two previously investigated cell lines. Interestingly,
alkaline phosphatase staining of human ES cells indicates that these
cells remain undifferentiated for at least 2 days after plating (Figure
4B). It is intriguing that such a simple surface can propagate human
embryonic stem cells. This result bodes well for finding optimized
surfaces for long-term ES cell proliferation and controlled dif-
ferentiation.
(1) (a) Singhvi, R.; Kumar, A.; Lopez, G. P.; Stephanopoulos, G. N.; Wang,
D. I. C.; Whitesides, G. M.; Ingber, D. E. Science 1994, 264, 696-698.
(b) Yousaf, M. N.; Houseman, B. T.; Mrksich, M. Proc. Natl. Acad. Sci.
U.S.A. 2001, 98, 5992-5996. (c) Jung, D. R.; Kapur, R.; Adams, T.;
Giuliano, K. A.; Mrksich, M.; Craighead, H. G.; Taylor, D. L. Crit. ReV.
Biotechnol. 2001, 21, 111-154.
(2) (a) Falsey, J. R.; Renil, M.; Park, S.; Li, S.; Lam, K. Bioconjugate Chem.
2001, 12, 346-353. (b) Hoff, A.; Andre, T.; Schaffer, T. E.; Jung, G.;
Wiesmuller, K.-H.; Brock, R. ChemBioChem 2002, 2, 1183-1191. (c)
Aina, O. H.; Sroka, T. C.; Chen, M.-L.; Lam, K. S. Biopolymers 2002,
66, 184-199. (d) Ito, Y.; Nogawa, M. Biomaterials 2003, 24, 3021-
3026.
(3) Bain, C. D.; Troughton, E. B.; Tao, Y.-T, Evall, J.; Whitesides, G. M.;
Nuzzo, R. G. J. Am. Chem. Soc. 1989, 111, 321-335.
(4) (a) Stenger, D. A.; Georger, J. H.; Dulcey, C. S.; Hickman, J. J.; Rudolph,
A. S.; Nielsen, T. B.; McCort, S. M.; Calvert, J. M. J. Am. Chem. Soc.
1992, 114, 8435-8442. (b) Lopez, G. P.; Albers, M. W.; Schreiber, S.
L.; Carroll, R.; Peralta, E.; Whitesides, G. M. J. Am. Chem. Soc. 1993,
115, 5877-5878. (c) Spargo, B. J.; Testoff, M. A.; Nielsen, T. B.; Stenger,
D. A.; Hickman, J. J.; Rudolph, A. S. Proc. Natl. Acad. Sci. U.S.A. 1994,
91, 11070-11074.
(5) (a) Margel, S.; Vogler, E. A.; Firment, L.; Watt, T.; Haynie, S.; Sogah,
D. Y. J. Biomed. Mater. Res. 1993, 27, 1463-1476. (b) Ranieri, J. P.;
Bellamkonda, R.; Jacob, J.; Vargo, T. G.; Gardella, J. A.; Aebischer, P.
J. Biomed. Mater. Res. 1993, 27, 917-925.
(6) See Supporting Information.
(7) Luk, Y. Y.; Kato, M.; Mrksich, M. Langmuir 2000, 16, 9604-9608.
(8) Sorribas, H.; Padeste, C.; Tiefenauer, L. Biomaterials 2002, 23, 893-
900.
(9) (a) Graupe, M.; Koini, T.; Wang, V. Y.; Nassif, G. M.; Colorado, R.;
Villazana, R. J.; Dong, H.; Miura, Y. F.; Shmakova, O. E.; Lee, T. R. J.
Fluorine Chem. 1999, 93, 107-115. (b) Naud, C.; Calas, P.; Blancou H.;
Commeyras A. J. Fluorine Chem. 2000, 104, 173-183.
(10) Pierschbacher, M. D.; Ruoslahti, E. Nature 1984, 309, 30-33.
(11) Graf, J.; Iwamoto, Y.; Sasaki, M.; Martin, G. R.; Kleinman, H. K.; Robey,
F. A.; Yamada, Y. Cell 1987, 48, 989-996.
(12) Houseman, B. T.; Mrksich, M. J. Org. Chem. 1998, 63, 7552-7555.
(13) Thomson, J. A.; Itskovitz-Eldor, J.; Shapiro, S. S.; Waknitz, M. A.;
Swiergiel, J. J.; Marshall, V. S.; Jones, J. M. Science 1998, 282, 1145-7.
(14) Xu, C.; Inokuma, M. S.; Denham, J.; Golds, K.; Kundu, P.; Gold, J. D.;
Carpenter, M. K. Nat. Biotechnol. 2001, 19, 971-974.
JA0474291
9
J. AM. CHEM. SOC. VOL. 126, NO. 35, 2004 10809